vVardis Secures $175 Million Funding Round Before NYSE Debut
Swiss oral-care startup vVardis has raised $175 million in a pre-IPO round as it prepares to list on the New York Stock Exchange.
Swiss luxury oral-care company vVardis has completed a $175 million fundraising round ahead of its planned initial public offering on the New York Stock Exchange, according to a pre-market advisory issued directly from the NYSE trading floor on Nov. 13, 2026.
The capital raise signals strong investor appetite for the brand ahead of its public market debut. vVardis, known for premium dental-care products, is positioning the NYSE listing as a step toward broader commercial expansion, though specific use-of-proceeds details were not disclosed in the advisory.
Read more Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day →
The NYSE issues daily pre-market updates from its trading floor to give investors early visibility into notable developments, listings, and market-moving news before the opening bell. The vVardis announcement was highlighted as part of that morning briefing, underscoring the company's significance among upcoming listings.
The funding round and pending IPO come at a time when consumer health and wellness brands have drawn considerable attention from both institutional and retail investors seeking growth opportunities outside traditional technology sectors. A successful listing would give vVardis access to public capital markets and heightened brand visibility in the United States.
Continue reading at Economic News, Trends, Analysis.
